Sartorius Stedim Biotech opens center for bioprocess innovation in USA
New research labs and process development services to enable next generation therapeutics
New research labs and process development services to enable next generation therapeutics
he company will focus on production of any pharmaceutical and biotechnological products
The company will also share results in two additional posters for deuruxolitinib
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
This two-day program was attended by 40 doctors & paramedical staff
        Subscribe To Our Newsletter & Stay Updated